Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8235 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8204 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD8360 |
Approved |
0.8187 |
Intermediate Similarity |
NPD8361 |
Approved |
0.8187 |
Intermediate Similarity |
NPD8435 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8114 |
Intermediate Similarity |
NPD8485 |
Approved |
0.8089 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.807 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7532 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7414 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7403 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7366 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7262 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7251 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6779 |
Approved |
0.72 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD6799 |
Approved |
0.716 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5403 |
Approved |
0.715 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7083 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7079 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD5494 |
Approved |
0.6983 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.698 |
Remote Similarity |
NPD7741 |
Discontinued |
0.697 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6966 |
Remote Similarity |
NPD7472 |
Approved |
0.695 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6949 |
Remote Similarity |
NPD7228 |
Approved |
0.6943 |
Remote Similarity |
NPD3764 |
Approved |
0.6941 |
Remote Similarity |
NPD37 |
Approved |
0.6941 |
Remote Similarity |
NPD1934 |
Approved |
0.6939 |
Remote Similarity |
NPD5951 |
Approved |
0.6936 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4966 |
Approved |
0.6919 |
Remote Similarity |
NPD3882 |
Suspended |
0.6919 |
Remote Similarity |
NPD4965 |
Approved |
0.6919 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6911 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6903 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD6764 |
Approved |
0.6889 |
Remote Similarity |
NPD6765 |
Approved |
0.6887 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD5408 |
Approved |
0.6852 |
Remote Similarity |
NPD5405 |
Approved |
0.6852 |
Remote Similarity |
NPD5406 |
Approved |
0.6852 |
Remote Similarity |
NPD5404 |
Approved |
0.6839 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6839 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD2533 |
Approved |
0.6826 |
Remote Similarity |
NPD2534 |
Approved |
0.6826 |
Remote Similarity |
NPD2532 |
Approved |
0.6813 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6802 |
Remote Similarity |
NPD2801 |
Approved |
0.6796 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6796 |
Remote Similarity |
NPD7240 |
Approved |
0.679 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6782 |
Remote Similarity |
NPD3749 |
Approved |
0.6781 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD5126 |
Approved |
0.6776 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6776 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD2182 |
Approved |
0.6748 |
Remote Similarity |
NPD2796 |
Approved |
0.6746 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD6784 |
Approved |
0.6739 |
Remote Similarity |
NPD6785 |
Approved |
0.6732 |
Remote Similarity |
NPD8328 |
Phase 3 |
0.673 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6728 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6711 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6705 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6702 |
Remote Similarity |
NPD8285 |
Discontinued |
0.669 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6688 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6687 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD3750 |
Approved |
0.6686 |
Remote Similarity |
NPD1512 |
Approved |
0.6685 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7095 |
Approved |
0.6667 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6667 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6644 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD6010 |
Discontinued |
0.6625 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6624 |
Remote Similarity |
NPD1470 |
Approved |
0.6623 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6606 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD1237 |
Approved |
0.6585 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6585 |
Remote Similarity |
NPD3748 |
Approved |
0.6585
|
Remote Similarity |
NPD7305 |
Phase 1 |